Role of adjuvant treatment in stage IB non-small cell lung carcinoma
Translational Lung Cancer Research · 2023-03 · 12 (3) · 649-652
DOI: 10.21037/tlcr-2023-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Lung Cancer Research, 2023-03. Verfasst von Cheol-Kyu Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Jeonnam, Republic of Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Chonnam National University Medical School and Hwasun Hospital, Jeonnam, Republic of Korea.
Zitieren
APA
Park, C. K., Oh, I. J., & Kim, Y. C. (2023). Role of adjuvant treatment in stage IB non-small cell lung carcinoma. Translational Lung Cancer Research, 12(3), 649-652. https://doi.org/10.21037/tlcr-2023-1
Vancouver
Park CK, Oh IJ, Kim YC. Role of adjuvant treatment in stage IB non-small cell lung carcinoma. Translational Lung Cancer Research. 2023;12(3):649-652. doi:10.21037/tlcr-2023-1
BibTeX
@article{Park2023,
author = {Park, Cheol-Kyu and Oh, In-Jae and Kim, Young-Chul},
title = {Role of adjuvant treatment in stage IB non-small cell lung carcinoma},
journal = {Translational Lung Cancer Research},
year = {2023},
volume = {12},
number = {3},
pages = {649--652},
doi = {10.21037/tlcr-2023-1}
}
EUVIMED